JP2015527360A5 - - Google Patents

Download PDF

Info

Publication number
JP2015527360A5
JP2015527360A5 JP2015528460A JP2015528460A JP2015527360A5 JP 2015527360 A5 JP2015527360 A5 JP 2015527360A5 JP 2015528460 A JP2015528460 A JP 2015528460A JP 2015528460 A JP2015528460 A JP 2015528460A JP 2015527360 A5 JP2015527360 A5 JP 2015527360A5
Authority
JP
Japan
Prior art keywords
pharmaceutical formulation
trans
item
human
clomiphene citrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2015528460A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015527360A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/032659 external-priority patent/WO2014031177A1/en
Publication of JP2015527360A publication Critical patent/JP2015527360A/ja
Publication of JP2015527360A5 publication Critical patent/JP2015527360A5/ja
Withdrawn legal-status Critical Current

Links

JP2015528460A 2012-08-21 2013-03-15 トランス−クロミフェン製剤およびその使用 Withdrawn JP2015527360A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261691722P 2012-08-21 2012-08-21
US61/691,722 2012-08-21
PCT/US2013/032659 WO2014031177A1 (en) 2012-08-21 2013-03-15 Trans-clomiphene formulations and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017167061A Division JP2017206562A (ja) 2012-08-21 2017-08-31 トランス−クロミフェン製剤およびその使用

Publications (2)

Publication Number Publication Date
JP2015527360A JP2015527360A (ja) 2015-09-17
JP2015527360A5 true JP2015527360A5 (OSRAM) 2016-05-12

Family

ID=48014380

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015528460A Withdrawn JP2015527360A (ja) 2012-08-21 2013-03-15 トランス−クロミフェン製剤およびその使用
JP2017167061A Pending JP2017206562A (ja) 2012-08-21 2017-08-31 トランス−クロミフェン製剤およびその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017167061A Pending JP2017206562A (ja) 2012-08-21 2017-08-31 トランス−クロミフェン製剤およびその使用

Country Status (22)

Country Link
US (1) US20150202167A1 (OSRAM)
EP (1) EP2887922A1 (OSRAM)
JP (2) JP2015527360A (OSRAM)
KR (1) KR20150041793A (OSRAM)
CN (1) CN104582686A (OSRAM)
AU (1) AU2013306393A1 (OSRAM)
BR (1) BR112015002288A2 (OSRAM)
CA (1) CA2880388A1 (OSRAM)
CL (1) CL2015000311A1 (OSRAM)
CR (1) CR20150096A (OSRAM)
EA (1) EA201590421A1 (OSRAM)
HK (1) HK1209636A1 (OSRAM)
IL (1) IL236911A0 (OSRAM)
IN (1) IN2015DN01698A (OSRAM)
MX (1) MX2015001912A (OSRAM)
NI (1) NI201500022A (OSRAM)
NZ (1) NZ704679A (OSRAM)
PH (1) PH12015500331A1 (OSRAM)
SG (2) SG10201704820SA (OSRAM)
UA (1) UA113324C2 (OSRAM)
WO (1) WO2014031177A1 (OSRAM)
ZA (1) ZA201501124B (OSRAM)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA113291C2 (xx) 2011-08-04 2017-01-10 Метаболіти транскломіфену і їх застосування
HK1216502A1 (zh) 2012-11-02 2016-11-18 Repros Therapeutics Inc. 用於癌症治療的反式-克羅米芬
EP3015454A1 (en) * 2014-10-28 2016-05-04 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Stable solid form of trans-Clomiphene citrate
EP3015453B1 (en) 2014-10-28 2016-10-12 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Process for the preparation of Clomiphene
US11737934B2 (en) 2015-10-14 2023-08-29 Qfix Systems, Llc MRI compatible patient trolley
CA2989364C (en) 2016-04-22 2021-07-20 F.I.S. - Fabbrica Italiana Sintetici S.P.A. Process for the preparation of enclomiphene citrate having needle shaped crystal habit.
CA3098552A1 (en) 2019-11-14 2021-05-14 Apotex Inc. Processes for the preparation of zuclomiphene and intermediates thereof
CA3098725A1 (en) 2019-11-14 2021-05-14 Apotex Inc. Zuclpomiphene salts and crystalline forms thereof
CA3105944A1 (en) * 2020-01-22 2021-07-22 Apotex Inc. Crystalline forms of zuclomiphene citrate
EP3907213A1 (en) 2020-05-04 2021-11-10 Pcas Processes for the production of isomerically pure or enriched cis-clomiphene
US11578025B2 (en) 2020-10-19 2023-02-14 Apotex Inc. Processes for the preparation of zuclomiphene intermediates

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2914563A (en) 1957-08-06 1959-11-24 Wm S Merrell Co Therapeutic composition
IT951631B (it) 1971-03-18 1973-07-10 Richardson Merrell Spa Composti utili per la separazione di isomeri ottici geometrici e strutturali e relativo procedimen to di sintesi
DK1411916T3 (da) * 2001-07-09 2008-12-15 Repros Therapeutics Inc Fremgangsmåder og materialer til behandling af testosteronmangel hos mænd
CN1965234A (zh) * 2004-03-31 2007-05-16 特罗弗根公司 人糖蛋白激素超激动剂及其用途
BRPI0513129A (pt) 2004-07-14 2008-04-29 Repros Therapeutics Inc método de tratamento de condição selecionada do grupo que consiste em hipertrofia benigna de próstata, cáncer de próstata, trigliceridos elevados, colesterol alto e hipogonadismo
CA2642761A1 (en) * 2006-02-23 2007-08-30 Iomedix Sleep International Srl Compositions and methods for the induction and maintenance of quality sleep
CN102940619A (zh) 2007-10-16 2013-02-27 利普生物药剂公司 用于治疗代谢综合征的珠氯米芬
TW201500041A (zh) * 2008-11-07 2015-01-01 Repros Therapeutics Inc 用於代謝症候群與第2型糖尿病的反式氯米芬

Similar Documents

Publication Publication Date Title
JP2015527360A5 (OSRAM)
JP2016540021A5 (OSRAM)
JP2017057230A5 (OSRAM)
WO2012079092A3 (en) Testosterone undecanoate compositions
JP2015038149A5 (OSRAM)
JP2013529665A5 (OSRAM)
JP2018527305A5 (OSRAM)
TN2012000362A1 (en) Rifaximin powder, process for preparing the same and controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect
MY207496A (en) Sustained-release formulations of colchicine and methods of using same
JP2016515628A5 (OSRAM)
JP2017506624A5 (OSRAM)
EA201492010A1 (ru) Применение высокой дозы лахинимода для лечения рассеянного склероза
RU2011152105A (ru) Составы таблеток 3-цианохинолина и их применение
RU2013154355A (ru) Способ лечения мезотелиомы ингибитором рi3к
PH12013500173A1 (en) Oral controlled release pharmaceutical compositions of blonanserin
JP2012526806A (ja) リコピンおよびレスベラトロールの栄養補助食品
JP2014529584A5 (OSRAM)
JP5564499B2 (ja) 前立腺癌の進行を予防または減退させるのに有効な組成物
JP2016069375A (ja) 前立腺肥大症の治療及び/又は前立腺肥大症による排尿障害の改善におけるバナナ花抽出物の用途
MX2013003523A (es) Composicion farmaceutica de dosis baja.
EP2575456A4 (en) COMPOSITIONS AND METHODS FOR TREATING PRESENTATIONS
HRP20161796T1 (hr) Farmaceutski pripravak za primjenu u tretmanu ili prevenciji deficijencije vitamina i minerala kod pacijenata podvrgnutih operaciji želučane premosnice
JP2016514706A5 (OSRAM)
RU2017112748A (ru) Композиции онапристона пролонгированного действия и способы
JP2017527627A (ja) 喫煙者における非小細胞肺癌の治療のための、カルボプラチンおよびパクリタキセルと併用したベリパリブ